Genpact today announced that it has signed a five-year contract with global pharma major GlaxoSmithKline [Get Quote] to provide finance and accounting functions for its US operations.

Genpact, which already has a contract for the GSK's [Get Quote] UK-based operations, declined to divulge the size of the deal.

"This agreement marks another milestone in our growing relationship with GlaxoSmithKline worldwide. This development is a testimony to our process excellence and domain expertise, especially in financial services. We look forward to working with GlaxoSmithKline to help drive continuous improvement and productivity for the global healthcare major," said Pramod Bhasin, president and CEO, Genpact.

As part of the deal, Genpact will support the company's US-based accounts payable, fixed assets, general accounting, process planning, travel & expense and business applications support, the company press release said.

GSK will maintain a small workforce to oversee the operations on an ongoing basis, the release said.